| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-09 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-09 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.25 | 9e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.16 | 6e-06 |